June 24th, 2016 Natixis Partners advised Sequana in the disposal of Arjowiggins Healthcare to Meeschaert Private Equity

Arjowiggins (Sequana Group) completed the sale of Arjowiggins Healthcare to Meeschaert Private Equity in partnership with the company’s executive management team. The proceeds from the sale will help strengthen Arjowiggins’ financing capacity.

Arjowiggins Healthcare holds leading positions in sterile packaging solutions via the Sterimed and Sterisheet brands. It produces and converts papers and substrates used to package sterile medical devices such as syringes, healthcare kits, gowns, drapes, gauzes and catheters.

Arjowiggins Healthcare employs over 330 people in four international sites (France, USA, Czech Republic and China) and delivers its products to hospitals, medical device manufacturers and special packaging players in over 70 countries. It reported annual consolidated sales of approximately €77 million in 2015.

‹ Back to news

M&A team:

anne hiebler
managing director

erwan thébault
executive director

wael daïf

Debt Advisory Team:

philippe charbonnier
managing director

patrice raulin